Capitalizing leadership acumen
for life science innovations

About Us


 

We advise, invest in and raise capital
for private and public life science companies

 

Areas of Focus

 
 
Disease Areas
mask group 29
NEUROLOGY
mask group 30
RARE DISEASE 
mask group 31
ONCOLOGY
mask group 32
CARDIOVASCULAR
Modalities
                   
 
mask group 36
GENE THERAPY
mask group 35
RNA
mask group 34
SMALL MOLECULES
mask group 33
BIOLOGICS
Modalities
For clients in the US and worldwide, we provide:
Allele Capital Partners believes in partnering with people who strongly value integrity and have a passion to make a meaningful impact in patients’ lives through life science innovations.

Testimonials


 

NEWS


View all news >
  • Jun 02, 2022

    BETHESDA, Md., June 02, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”,...



  • May 18, 2022

    BETHESDA, Md., May 18, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or...



  • May 16, 2022

    Presented Supportive Preclinical Data for Lead Candidate GT-02287 at Recent Medical Meetings...